Bruno A. Duso

1.4k total citations · 1 hit paper
21 papers, 879 citations indexed

About

Bruno A. Duso is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bruno A. Duso has authored 21 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bruno A. Duso's work include Cancer Genomics and Diagnostics (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Advanced Breast Cancer Therapies (4 papers). Bruno A. Duso is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Advanced Breast Cancer Therapies (4 papers). Bruno A. Duso collaborates with scholars based in Italy, Brazil and United States. Bruno A. Duso's co-authors include Giuseppe Curigliano, Paolo D’Amico, Carmen Belli, Dario Trapani, Giulia Viale, Emanuela Ferraro, Paolo Della Vigna, Franco Orsi, Paolo Tarantino and Stefania Morganti and has published in prestigious journals such as Cancer Research, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Bruno A. Duso

19 papers receiving 866 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting the microenvironment in solid tumors

2018 385 citations Carmen Belli, Dario Trapani et al. Cancer Treatment Reviews profile →

Peers

Bruno A. Duso

ONCOL

IMMUN

PRM

Laura Stanbery United States

Shengnan Yu China

Catalin Mihalcioiu Canada

Si-Qi Qiu China

Huimin Tian China

Yongsheng Wang China

Marta Santisteban Spain

Roberto A. Leon‐Ferre United States

Julian A. Gingold United States

Khashayar Esfahani Canada

Laura Stanbery United States

Bruno A. Duso

557 ×1.3

ONCOL

441 ×1.2

242 ×0.9

273 ×1.4

IMMUN

198 ×1.1

PRM

Citations per year, relative to Bruno A. Duso Bruno A. Duso (= 1×) peers Laura Stanbery

Countries citing papers authored by Bruno A. Duso

Since Specialization

Citations

This map shows the geographic impact of Bruno A. Duso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno A. Duso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno A. Duso more than expected).

Fields of papers citing papers by Bruno A. Duso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno A. Duso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno A. Duso. The network helps show where Bruno A. Duso may publish in the future.

Co-authorship network of co-authors of Bruno A. Duso

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno A. Duso. A scholar is included among the top collaborators of Bruno A. Duso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno A. Duso. Bruno A. Duso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Trapani, Dario, Bruno A. Duso, Paolo Beria, et al.. (2022). Quantifying geographical accessibility to cancer clinical trials in different income landscapes. ESMO Open. 7(3). 100515–100515. 7 indexed citations

Duso, Bruno A., Elena Gavilán, Maria De Filippo, et al.. (2022). Abstract 1164: Somatic NF1 loss in breast cancer leads to centrosome amplification, aneuploidy and increased sensitivity to T-DM1. Cancer Research. 82(12_Supplement). 1164–1164.

Ferrucci, Pier Francesco, Bruno A. Duso, Luigi Nezi, et al.. (2022). Abstract CT167: Neoadjuvant ipilimumab/nivolumab in locally advanced or oligometastatic melanoma: An open label, single arm, multi-institutional clinical study with molecular and immunological biomarker’s analysis. Cancer Research. 82(12_Supplement). CT167–CT167. 1 indexed citations

Duso, Bruno A., Elena Gavilán, Maria R. Ippolito, et al.. (2022). Abstract P5-13-04: NF1 mutations render HER2+ breast cancer highly sensitive to T-DM1 by altering microtubule dynamics. Cancer Research. 82(4_Supplement). P5–13. 3 indexed citations

Mazzarella, Luca, Silvia Giugliano, Paolo D’Amico, et al.. (2020). Evidence for interleukin 17 involvement in severe immune-related neuroendocrine toxicity. European Journal of Cancer. 141. 218–224. 14 indexed citations

Duso, Bruno A., Dario Trapani, Antonio Marra, et al.. (2020). Pharmacological management of male breast cancer. Expert Opinion on Pharmacotherapy. 21(12). 1493–1504. 7 indexed citations

Gandini, Sara, Ines Zanna, Simone Pietro De Angelis, et al.. (2020). Circulating tumour DNA and melanoma survival: A systematic literature review and meta-analysis. Critical Reviews in Oncology/Hematology. 157. 103187–103187. 26 indexed citations

Duso, Bruno A., Federica Bellerba, Federica Corso, et al.. (2020). Semantic and Geographical Analysis of COVID-19 Trials Reveals a Fragmented Clinical Research Landscape Likely to Impair Informativeness. Frontiers in Medicine. 7. 367–367. 7 indexed citations

Mazzarella, Luca, Bruno A. Duso, Dario Trapani, et al.. (2019). The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review. European Journal of Cancer. 117. 14–31. 80 indexed citations

10.

Belli, Carmen, Bruno A. Duso, Emanuela Ferraro, & Giuseppe Curigliano. (2019). Homologous recombination deficiency in triple negative breast cancer. The Breast. 45. 15–21. 59 indexed citations

11.

Tarantino, Paolo, Dario Trapani, Stefania Morganti, et al.. (2019). Opportunities and challenges of implementing Pharmacogenomics in cancer drug development. Cancer Drug Resistance. 2(1). 43–52. 2 indexed citations

12.

Duso, Bruno A., et al.. (2019). Secondary mechanisms of anti-HER2 resistance in breast cancer: NF1 as an actionable target. Annals of Oncology. 30. iii6–iii7.

13.

Morganti, Stefania, Paolo Tarantino, Emanuela Ferraro, et al.. (2019). Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer. Advances in experimental medicine and biology. 9–30. 148 indexed citations

14.

Belli, Carmen, Massimo Zuin, Luca Mazzarella, et al.. (2018). Liver toxicity in the era of immune checkpoint inhibitors: A practical approach. Critical Reviews in Oncology/Hematology. 132. 125–129. 21 indexed citations

15.

Morganti, Stefania, Paolo Tarantino, Emanuela Ferraro, et al.. (2018). Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life. Critical Reviews in Oncology/Hematology. 133. 171–182. 88 indexed citations

16.

Duso, Bruno A., Dario Trapani, Giulia Viale, et al.. (2018). Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer. Expert Opinion on Pharmacotherapy. 19(3). 299–305. 4 indexed citations

17.

Belli, Carmen, Dario Trapani, Giulia Viale, et al.. (2018). Targeting the microenvironment in solid tumors. Cancer Treatment Reviews. 65. 22–32. 385 indexed citations breakdown →

18.

Rosa, Régis Goulart, Túlio Frederico Tonietto, Bruno A. Duso, et al.. (2017). Mortality of Adult Critically Ill Subjects With Cancer. Respiratory Care. 62(5). 615–622. 8 indexed citations

19.

Neto, Felippe Leopoldo Dexheimer, Régis Goulart Rosa, Bruno A. Duso, et al.. (2016). Public versus Private Healthcare Systems following Discharge from the ICU: A Propensity Score-Matched Comparison of Outcomes. BioMed Research International. 2016. 1–8. 8 indexed citations

20.

Kneubil, Maximiliano Cassilha, Edoardo Botteri, Nicole Rotmensz, et al.. (2013). Locoregional recurrence in patients with HER2 positive breast cancer. The Breast. 22(5). 856–862. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact